Clarivate VIVO Sandbox

Academic Articles457

• (2019). Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma. CANCER IMMUNOLOGY IMMUNOTHERAPY. 68(7), 1059-1071.

  
• (2019). Inhibition of murine hepatoma tumor growth by cryptotanshinone involves TLR7-dependent activation of macrophages and induction of adaptive antitumor immune defenses. CANCER IMMUNOLOGY IMMUNOTHERAPY. 68(7), 1073-1085.

  
• (2019). Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. JOURNAL OF IMMUNOLOGY. 202(1), 5-9.
• (2018). Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer. Science Signaling. 11(511),

  
• (2018). Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice. Journal for ImmunoTherapy of Cancer. 7,

  
• (2018). HMGN1 and R848 Synergistically Activate Dendritic Cells Using Multiple Signaling Pathways. Frontiers in Immunology. 9,

  
• (2018). High-Mobility Group Nucleosome-Binding Protein 1 as Endogenous Ligand Induces Innate Immune Tolerance in a TLR4-Sirtuin-1 Dependent Manner in Human Blood Peripheral Mononuclear Cells. Frontiers in Immunology. 9,

  
• (2018). High-mobility group nucleosome binding domain 1 (HMGN1) functions as a Th1-polarizing alarmin. SEMINARS IN IMMUNOLOGY. 38(C), 49-53.

  
• (2018). The Future of the Cytokine Discipline. Cold Spring Harbor Perspectives in Biology. 10(9),

  
• (2017). A Role for Neuronal Alpha-Synuclein in Gastrointestinal Immunity. Journal of Innate Immunity. 9(5), 456-463.

  
• (2017). Alarmins and immunity. IMMUNOLOGICAL REVIEWS. 280(1), 41-56.

  
• (2017). Development of a Curative Therapeutic Vaccine (TheraVac) for the Treatment of Large Established Tumors. Scientific Reports. 7,

  
• (2017). Shock Synthesis of Decagonal Quasicrystals. Scientific Reports. 7,

  
• (2017). Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer. Science Signaling. 10(462),

  
• (2017). Therapeutic vaccine to cure large mouse hepatocellular carcinomas. 8(32), 52061-52071.

  
• (2016). Alarmin human a defensin HNP1 activates plasmacytoid dendritic cells by triggering NF-kappa B and IRF1 signaling pathways. CYTOKINE. 83, 53-60.

  
• (2016). Alarmins and Antitumor Immunity. CLINICAL THERAPEUTICS. 38(5), 1042-1053.

  
• (2016). IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization. JOURNAL OF EXPERIMENTAL MEDICINE. 213(10), 2147-2166.

  
• (2016). Paradoxical effects of targeting TNF signalling in the treatment of autoimmunity. Nature Reviews Rheumatology. 12(11), 625-626.

  
• (2016). Suppressive activity of human regulatory T cells is maintained in the presence of TNF. NATURE MEDICINE. 22(1), 16-+.

  
• (2016). TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitis. Scientific Reports. 6,

  
• (2016). TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitis (vol 6, 32834, 2016). Scientific Reports. 6,

  
• (2015). Characterization of MT-2 cells as a human regulatory T cell-like cell line. Cellular & Molecular Immunology. 12(6), 780-782.

  
• (2015). Enhanced immunostimulatory effects of DNA-encapsulated peptide hydrogels. BIOMATERIALS. 53, 545-553.

  
• (2015). Harnessing the alarmin HMGN1 for anticancer therapy. Immunotherapy. 7(11), 1129-1131.